These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2113590)

  • 1. Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients.
    Huland H; Klöppel G; Feddersen I; Otto U; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F; Huland E
    J Urol; 1990 Jul; 144(1):68-71; discussion 71-2. PubMed ID: 2113590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors.
    Huland H; Klöppel G; Otto U; Feddersen I; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F
    Eur Urol; 1988; 14(3):202-6. PubMed ID: 3133216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term results of intravesical prevention of recurrence with mitomycin C and adriamycin in patients with superficial bladder cancer].
    Schwaibold H; Klingenberger HJ; Huland H
    Urologe A; 1994 Nov; 33(6):479-83. PubMed ID: 7817443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of cytostatic intravesical instillation in patients with superficial bladder carcinoma. Is short-term, intensive instillation better than maintenance therapy?
    Schwaibold H; Pichlmeier U; Klingenberger HJ; Huland H
    Eur Urol; 1997; 31(2):153-9. PubMed ID: 9076457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results. The Hokkaido University Bladder Cancer Collaborating Group.
    Togashi M; Shinohara N; Toyota K; Koyanagi T; Maru A; Fujieda J; Kawakura K; Nishida T; Ohashi N
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S21-5. PubMed ID: 1394811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer.
    Tsushima T; Matsumura Y; Ozaki Y; Yoshimoto J; Ohmori H
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S72-6. PubMed ID: 3117400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer.
    Chen CH; Yang HJ; Shun CT; Huang CY; Huang KH; Yu HJ; Pu YS
    Urol Oncol; 2012; 30(4):421-7. PubMed ID: 20870427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical instillation of mitomycin-C in 242 patients with superficial bladder cancer at high risk of recurrence: long-term results.
    Hurle R; Manzetti A; Losa A; Micheli E; Ranieri A; Chinaglia D; Lembo A
    Urol Int; 1998; 61(4):220-6. PubMed ID: 10364753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.
    Ueda T; Naito S; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S31-6. PubMed ID: 1394813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA; Van Helsdingen PJ; Kramer AE
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic intravesical instillation therapy with adriamycin (ADM) and mitomycin C (MMC) in patients with superficial bladder cancer].
    Ozaki Y; Tsushima T; Nasu Y; Akagi T; Obama T; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1493-500. PubMed ID: 3100850
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
    Kim HH; Lee C
    J Urol; 1989 Jun; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors.
    Fukui I; Sekine H; Kihara K; Yamada T; Kawai T; Washizuka M; Ishiwata D; Oka K; Hosoda K; Ikegami S
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S52-5. PubMed ID: 3117399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Can topical chemoprevention modify the rate of recurrence and progression of superficial bladder cancer?].
    Egghart G; Steegmüller O; Wenderoth U; Hautmann R
    Urologe A; 1988 May; 27(3):147-51. PubMed ID: 3136576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder cancer.
    Isaka S; Okano T; Abe K; Shimazaki J
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S41-4. PubMed ID: 1394815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group.
    Akaza H; Isaka S; Koiso K; Kotake T; Machida T; Maru A; Matsumura Y; Niijima T; Obata K; Ohe H
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S91-6. PubMed ID: 3117403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C.
    Isaka S; Okano T; Shimazaki J; Igarashi T; Murakami S; Higa T; Ishikawa T; Zama S; Kataumi S; Kataumi Z
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S77-80. PubMed ID: 3117401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly mitomycin C followed by monthly bacillus Calmette-Guerin or alternating monthly interferon-alpha2B and bacillus Calmette-Guerin for prophylaxis of recurrent papillary superficial bladder carcinoma.
    Kaasinen E; Rintala E; Pere AK; Kallio J; Puolakka VM; Liukkonen T; Tuhkanen K
    J Urol; 2000 Jul; 164(1):47-52. PubMed ID: 10840422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
    van der Meijden AP; DeBruyne FM
    Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.